よむ、つかう、まなぶ。
【参考資料２－２】抗微生物薬適正使用の手引き 第四版（案）医科・入院編 (41 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/newpage_64503.html |
| 出典情報 | 厚生科学審議会 感染症部会（第99回 10／21）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
抗微生物薬適正使用の手引き
第四版
医科・入院編
1
2
20. Spellberg B, et al. New Societal Approaches to Empowering Antibiotic Stewardship.
JAMA. 2016. 315(12):1229-1230.
3
4
5
21. Willems RPJ, et al. Incidence of infection with multidrug-resistant Gram-negative
bacteria and vancomycin-resistant enterococci in carriers: a systematic review and
meta-regression analysis. The Lancet Infectious Diseases. 2023.
6
7
22. Bennett JE, et al. Mandell, Douglas, and Bennett's Principles and Practice of Infectious
Diseases. 9th ed. Philadelphia: Elsevier; 2019.
8
9
10
23. 抗菌薬適正使用支援プログラム実践のためのガイダンス 8 学会合同抗微生物薬適正使用
推進検討委員会 感染症学雑誌, 第 91 巻, 第 5 号
https://www.kansensho.or.jp/uploads/files/guidelines/1708_ASP_guidance.pdf
11
12
24. Dryden M, et al. Using antibiotics responsibly: right drug, right time, right dose, right
duration. J Antimicrob Chemother. 2011. 66(11):2441-2443.
13
14
15
25. Schuler F, et al. Prevalence and risk factors for bacteremia in patients with
Staphylococcus aureus bacteriuria: A retrospective cohort study. Int J Infect Dis. 2020.
98:467-469.
16
17
18
26. Weinstein MP, et al. The clinical significance of positive blood cultures in the 1990s: a
prospective comprehensive evaluation of the microbiology, epidemiology, and outcome
of bacteremia and fungemia in adults. Clin Infect Dis. 1997. 24(4):584-602.
19
20
27. Pien BC, et al. The clinical and prognostic importance of positive blood cultures in
adults. Am J Med. 2010. 123(9): 819-828
21
22
28. Hodnett ED, et al. Re-conceptualizing the hospital labor room: the PLACE (pregnant and
laboring in an ambient clinical environment) pilot trial. Birth. 2009. 36(2):159-166.
23
24
25
26
27
28
29
29. Torres A, et al. International ERS/ESICM/ESCMID/ALAT guidelines for the management
of hospital-acquired pneumonia and ventilator-associated pneumonia: Guidelines for the
management of hospital-acquired pneumonia (HAP)/ventilator-associated pneumonia
(VAP) of the European Respiratory Society (ERS), European Society of Intensive Care
Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases
(ESCMID) and Asociación Latinoamericana del Tórax (ALAT). Eur Respir J. 2017.
50(3):1700582.
30
31
32
30. Janmaimool P, et al. Evaluating determinants of environmental risk perception for risk
management in contaminated sites. Int J Environ Res Public Health. 2014. 11(6):62916313.
33
34
35
36
31. Gupta K, et al. International clinical practice guidelines for the treatment of acute
uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious
Diseases Society of America and the European Society for Microbiology and Infectious
Diseases. Clin Infect Dis. 2011. 52(5):e103-120.
37
38
32. Pardo J, et al. Time to positivity of blood cultures supports antibiotic de-escalation at 48
hours. The Annals of pharmacotherapy. 2014. 48(1):33-40.
39
40
41
33. Puerta-Alcalde P, et al. Current time-to-positivity of blood cultures in febrile neutropenia:
a tool to be used in stewardship de-escalation strategies. Clin Microbiol Infect. 2019.
25(4):447-453.
42
34. Diagn Microbiol Infect Dis 1993;17:103-9.
43
44
45
35. Mandell LA, et al. Infectious Diseases Society of America/American Thoracic Society
consensus guidelines on the management of community-acquired pneumonia in adults.
Clin Infect Dis. 2007. 44 Suppl 2(Suppl 2):S27-72.
41
第四版
医科・入院編
1
2
20. Spellberg B, et al. New Societal Approaches to Empowering Antibiotic Stewardship.
JAMA. 2016. 315(12):1229-1230.
3
4
5
21. Willems RPJ, et al. Incidence of infection with multidrug-resistant Gram-negative
bacteria and vancomycin-resistant enterococci in carriers: a systematic review and
meta-regression analysis. The Lancet Infectious Diseases. 2023.
6
7
22. Bennett JE, et al. Mandell, Douglas, and Bennett's Principles and Practice of Infectious
Diseases. 9th ed. Philadelphia: Elsevier; 2019.
8
9
10
23. 抗菌薬適正使用支援プログラム実践のためのガイダンス 8 学会合同抗微生物薬適正使用
推進検討委員会 感染症学雑誌, 第 91 巻, 第 5 号
https://www.kansensho.or.jp/uploads/files/guidelines/1708_ASP_guidance.pdf
11
12
24. Dryden M, et al. Using antibiotics responsibly: right drug, right time, right dose, right
duration. J Antimicrob Chemother. 2011. 66(11):2441-2443.
13
14
15
25. Schuler F, et al. Prevalence and risk factors for bacteremia in patients with
Staphylococcus aureus bacteriuria: A retrospective cohort study. Int J Infect Dis. 2020.
98:467-469.
16
17
18
26. Weinstein MP, et al. The clinical significance of positive blood cultures in the 1990s: a
prospective comprehensive evaluation of the microbiology, epidemiology, and outcome
of bacteremia and fungemia in adults. Clin Infect Dis. 1997. 24(4):584-602.
19
20
27. Pien BC, et al. The clinical and prognostic importance of positive blood cultures in
adults. Am J Med. 2010. 123(9): 819-828
21
22
28. Hodnett ED, et al. Re-conceptualizing the hospital labor room: the PLACE (pregnant and
laboring in an ambient clinical environment) pilot trial. Birth. 2009. 36(2):159-166.
23
24
25
26
27
28
29
29. Torres A, et al. International ERS/ESICM/ESCMID/ALAT guidelines for the management
of hospital-acquired pneumonia and ventilator-associated pneumonia: Guidelines for the
management of hospital-acquired pneumonia (HAP)/ventilator-associated pneumonia
(VAP) of the European Respiratory Society (ERS), European Society of Intensive Care
Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases
(ESCMID) and Asociación Latinoamericana del Tórax (ALAT). Eur Respir J. 2017.
50(3):1700582.
30
31
32
30. Janmaimool P, et al. Evaluating determinants of environmental risk perception for risk
management in contaminated sites. Int J Environ Res Public Health. 2014. 11(6):62916313.
33
34
35
36
31. Gupta K, et al. International clinical practice guidelines for the treatment of acute
uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious
Diseases Society of America and the European Society for Microbiology and Infectious
Diseases. Clin Infect Dis. 2011. 52(5):e103-120.
37
38
32. Pardo J, et al. Time to positivity of blood cultures supports antibiotic de-escalation at 48
hours. The Annals of pharmacotherapy. 2014. 48(1):33-40.
39
40
41
33. Puerta-Alcalde P, et al. Current time-to-positivity of blood cultures in febrile neutropenia:
a tool to be used in stewardship de-escalation strategies. Clin Microbiol Infect. 2019.
25(4):447-453.
42
34. Diagn Microbiol Infect Dis 1993;17:103-9.
43
44
45
35. Mandell LA, et al. Infectious Diseases Society of America/American Thoracic Society
consensus guidelines on the management of community-acquired pneumonia in adults.
Clin Infect Dis. 2007. 44 Suppl 2(Suppl 2):S27-72.
41